Morning Brief — July 31, 2026

Market Overview

Big Tech earnings are driving the tape today, with Microsoft posting its best single day since 2008 (+15.5%) on a blowout Azure quarter that validated the AI infrastructure thesis across the board. Amazon earnings beat is adding fuel pre-bell, pulling cloud and infrastructure names higher, while Apple is a notable drag after its own results disappointed — a split verdict that keeps the market roughly balanced. PCE came in at +3.7% YoY headline, still elevated, which keeps rate-cut hopes modest, but the AI spending supercycle narrative is clearly dominating investor attention over macro concerns this morning.

Claude’s Call

UP — Microsoft’s best day in nearly two decades is a tide-lifter for the entire AI ecosystem, and Amazon’s beat adds a second pillar of support heading into the weekend. Despite sticky PCE data, the market is choosing to party on capex acceleration and cloud re-acceleration; expect the S&P 500 to finish green, with tech leading and defensives lagging.

Top Movers

NWL (+31.4%) — $6.76 → $7.80 (+15.4% upside) Thesis: Newell Brands delivered a genuine earnings beat — EPS surprised by +121% and revenues beat by +1.28% — driven by product innovation, expanded retail distribution, and increased ad support that lifted demand across its portfolio. Net sales rose 3% to ~$2B, marking the first year-over-year growth return, and the company raised full-year normalized EPS guidance dramatically from $0.56-$0.60 to $0.73-$0.77 (a ~28% raise at midpoint). A tariff refund provided an additional boost. Technically, NWL is breaking out to a new 6-month high with the 50-day SMA way back at $4.83 — this move has fundamental legs, but a 31% single-day move on relatively muted volume (vol ratio 0.45x average) warrants caution about chasing here. The fib extension target at $7.80 is the logical first exit. Levels: Exit at $7.80 (fib ext 1.272). Support at $5.97 (fib 23.6% retracement).

FCEL (+30.6%) — $23.62 → $28.98 (+22.7% upside) Thesis: FuelCell is riding Bloom Energy’s coattails — this is pure sector sympathy driven by BE’s blockbuster Q2 results (earnings surge of 680%) and a Mizuho upgrade. FCEL itself has no company-specific catalyst today; this is a sympathy rally in the fuel-cell complex tied to AI power demand narrative. Technically, FCEL is bouncing off its 50-day SMA ($22.19) and approaching the 23.6% fib retracement at $28.98 from above its recent swing high of $36. This is the weakest kind of catalyst — sector sympathy with no company-specific news — and FCEL remains unprofitable. The setup is a bounce, not a breakout. Levels: Exit at $28.98 (fib 23.6% resistance). Support at $22.19 (50-day SMA); a break below $21.12 (fib 50%) is a stop.

PLPC (+30.0%) — $368.46 → $457.93 (+24.3% upside) Thesis: Preformed Line Products reported record Q2 results with revenue and earnings growth driven by strong energy/AI infrastructure demand and global expansion — this is a real, company-specific catalyst with expanding margins and a genuine “picks and shovels” AI infrastructure angle. Jim Cramer flagged this weeks ago as a legit AI infrastructure stack play, and the numbers are backing it up. Technically, PLPC has broken above the 23.6% fib retracement level ($369) and is approaching its 6-month high zone — the fib extension at $457.93 is the next meaningful target. Volume is light though (0.07x average), so conviction on the continuation is limited. Levels: Exit at $457.93 (fib ext 1.272). Support at $343.53 (fib 38.2%) and $359.57 (50-day SMA).

MKTX (+29.5%) — $162.76 → $192.55 (+18.3% upside, 6mo high) Thesis: This is a clean M&A deal — ICE is acquiring MarketAxess for $6 billion at a 33% premium to pre-announcement price. The math is straightforward: deal spreads suggest ~2-3% additional upside to the implied deal price, and the stock’s RSI of 30 pre-deal actually signals it was oversold before this catalyst hit. The 6-month high is $192.55, which aligns closely with the deal premium range. With a definitive agreement signed, this is now an arb play — not a momentum trade. Downside risk is deal collapse or regulatory block. Levels: Exit at $192.55 (deal premium / 6mo high). Support at $160.67 (fib 38.2% — likely holds given deal floor).

BHC (+28.9%) — $6.03 → $6.69 (+10.9% upside) Thesis: Bausch Health swung to net income of $260 million in Q2, marking its 13th consecutive quarter of revenue and adjusted EBITDA growth, driven by Salix, Solta Medical, and Bausch + Lomb. The company raised 2026 revenue and EBITDA guidance following a genuine turnaround print. At $6.03, BHC is pressing against the fib extension at $6.69 and the next target is $7.30. This is a legitimate recovery story, but the debt load remains substantial — this is a trading position, not an investment. Levels: Exit at $6.69 (fib ext 1.272). Support at $5.53 (fib 38.2%).

CORT (+27.3%) — $118.32 → $141.76 (+19.8% upside) Thesis: Corcept Therapeutics delivered a monster quarter — revenue up 32% to $256.1M, with a $47.6M contribution in the first quarter from Lifyorli (new ovarian cancer drug), and EPS surprise of +1,000% (note: base was low). Full-year guidance was raised and the company is now a dual-franchise story with Cushing’s syndrome + oncology. This is one of the strongest fundamental catalysts on today’s board. Technically, CORT is pressing its 6-month high but the fib extension at $141.76 gives meaningful room. The RSI at 50 suggests not yet overbought despite the move. Levels: Exit at $141.76 (fib ext 1.272). Support at $97.98 (fib 23.6%) — that’s a wide stop, appropriate for a volatile biotech.

MSFT (+15.5%) — $451.10 → $489.81 (+8.6% upside) Thesis: This is the real deal — Microsoft’s Azure re-acceleration is the single most important data point for AI infrastructure bulls this earnings season. The company poured a record $41B into AI infrastructure and Azure growth responded by accelerating, validating the spend. The stock’s best day since 2008 is justified by the magnitude of the guidance signal — not just the quarter. Technically, MSFT is near its 6-month high ($460.52), with the fib extension at $489.81 the next target. The RSI at 13.89 is puzzlingly low for a stock at highs — likely a data artifact, but the move has institutional conviction behind it. Levels: Exit at $489.81 (fib ext 1.272). Support at $435.11 (fib 23.6%), then $419.38 (fib 38.2%).

MPWR (+14.7%) — $1,508.94 → $1,874.59 (+24.2% upside) Thesis: Monolithic Power Systems is the cleanest semiconductor play on today’s board — Enterprise Data revenue surged 164% YoY and 45% sequentially, record Q2 revenue of $981M (up 48% YoY), and management raised the full-year Enterprise Data growth outlook to 130%. This is a direct AI silicon beneficiary, not a sympathy play. Technically, MPWR is below its 6-month high of $1,687 but above its 23.6% fib support at $1,524 — the fib extension at $1,874 is realistic given the fundamental trajectory. Strong setup. Levels: Exit at $1,874.59 (fib ext 1.272). Support at $1,524.83 (fib 23.6%) / $1,447.32 (50-day SMA).

CMG (+12.5%) — $38.52 → $43.13 (+12.0% upside) Thesis: Chipotle beat Q2 profit expectations with EPS of $0.33 vs $0.32 consensus, 9.3% revenue growth to $3.35B, and a 2.2% comp acceleration — importantly, the company stated it is “not involved” in a cyclospora outbreak, removing an overhang. The comp acceleration is the real story here as it signals the traffic recovery is sustaining. Technically, CMG is approaching its 6-month high of $39.93, with the RSI at 68.8 — getting warm but not yet overbought. The fib extension at $43.13 is the clean target. Levels: Exit at $43.13 (fib ext 1.272). Support at $37.16 (fib 23.6%) / $35.44 (fib 38.2%).

IDCC (+16.2%) — $303.33 → $347.22 (+14.5% upside) Thesis: InterDigital crushed Q2 with $260.2M in revenue (beat of +80.65%) and a record $625.7M ARR, driven by a landmark Amazon patent license deal covering devices and Prime Video plus legal wins against Disney. This is a high-quality, non-recurring revenue surge from deal timing — the catch-up revenue is real but doesn’t sustain at this rate. Still, the ARR growth signals the licensing pipeline is robust. Technically, IDCC is below its 6-month high and below the 23.6% fib retracement at $347, which now becomes the target. RSI at 10.17 is deeply oversold — the previous pullback was overdone. Levels: Exit at $347.22 (fib 23.6% resistance from prior swing). Support at $298.67 (fib 61.8%) / $269.22 (50-day SMA).

Headlines to Watch

“Microsoft’s $41 Billion AI Bet Just Cleared a Major Test” — Azure re-acceleration after record capex spend is the single most bullish data point for AI infrastructure names this cycle; watch GOOGL and AWS-dependent names as read-throughs.
“Amazon Stock Soars After Q2 Earnings Beat — AI, Chip Businesses See $25 Billion Run Rate” — AWS reaching a $25B run rate in AI/chips validates the hyperscaler spend theme and is a direct positive for MPWR, PLPC, BDC, and the entire data center supply chain.
“PCE Data for June: +3.3% Core, +3.7% Headline — Elevated But In-Line” — Core PCE above 3% keeps the Fed on hold longer; risk assets can rally on earnings but rate-sensitive plays (utilities, REITs) remain under pressure.
“Reddit Stock Drops 15% Despite Q2 Beat — ‘Choppy’ Search Traffic Warning Spooks Investors” — Search traffic dependency is a structural vulnerability for RDDT; today’s WSB bullish sentiment is swimming against a deteriorating technical and fundamental setup.
“Nvidia Tanking Below $190 — One Analyst Targets 165% Gains” — NVDA breaking below key support while MSFT/MPWR/PLPC rally is a notable divergence within AI; watch whether NVDA finds a bid on the Microsoft halo or continues to lag.
“Chipotle Says It’s Not Involved in Cyclospora Outbreak” — Removing this overhang plus comp acceleration makes CMG a cleaner buy; restaurant sector broadly benefits as food safety fears fade.
“MarketAxess Agrees to Be Acquired by ICE at 33% Premium” — Clean deal arb; also signals that financial market infrastructure is still a hot M&A target — watch other electronic trading names like Tradeweb (TW) for sympathy.

Claude’s Top Picks

MSFT (+15.5% today, +18.2% week) — $451.10 → $489.81 (+8.6% upside) Valuation: No comp data provided, but at ~32x forward earnings on accelerating cloud growth with Azure re-acceleration, this is fair-to-cheap relative to its own history and the AI premium the market is assigning peers. Upside: Azure re-acceleration is the single most important AI spending validation event this earnings season, and institutional repositioning after a multi-week pullback (50-day SMA was $399) means catch-up buying has legs into next week. Risk: PCE staying elevated could prompt a rate-sentiment reversal that hits growth multiples; also, at just 8.6% from the 6-month high, the easy money in the single-day move may already be made. Stop reference: $435.11 (fib 23.6%)

MPWR (+14.7% today, +13.1% week) — $1,508.94 → $1,874.59 (+24.2% upside) Valuation: No comp data, but 164% Enterprise Data revenue growth and a 48% top-line expansion justify a premium multiple; MPWR typically trades at 50-70x forward earnings and the growth rate is re-accelerating. Upside: Enterprise Data at 130% full-year growth guidance is not priced in — this is the highest-quality direct AI silicon play in today’s mover list, with genuine revenue acceleration rather than sympathy moves. Risk: MPWR pulled from its $1,687 6-month high, and if NVDA’s weakness signals AI infrastructure spending fatigue at the chip layer, MPWR won’t be immune to sector rotation. Stop reference: $1,447.32 (50-day SMA)

CORT (+27.3% today, +22.4% week) — $118.32 → $141.76 (+19.8% upside) Valuation: Forward P/E of 24.5x vs peer median of 14.5x — technically EXPENSIVE vs peers, but a 32% revenue grower with a new oncology franchise launching at $47.6M in its first quarter deserves a growth premium; the EV/EBITDA of 1,545x is an artifact of early-stage profitability transition. Upside: Lifyorli is in its first quarter of contribution and already generating $47.6M — if this scales toward Korlym-level revenues, the forward earnings estimates will need significant upward revision. Risk: Biotech re-rating is fast and brutal; any clinical setback on Lifyorli expansion, generic competition on Korlym, or broader biotech sector selloff could erase this gain quickly. Stop reference: $97.98 (fib 23.6%)

CMG (+12.5% today, +20.3% week) — $38.52 → $43.13 (+12.0% upside) Valuation: No comp data provided, but Chipotle typically commands a 50-60x forward P/E as the premium fast-casual compounder; at current levels post-beat, the valuation is roughly in line with its own historical range. Upside: The 2.2% comp acceleration is the metric that matters most for Chipotle — it signals the traffic recovery is real, the cyclospora overhang is cleared, and the growth algorithm (new unit + comps) is back on track for H2. Risk: RSI at 68.8 is approaching overbought territory, and the 6-month high at $39.93 is just 3.6% away — a brief consolidation before the $43 target is more likely than a straight shot up. Stop reference: $37.16 (fib 23.6%)

NWL (+31.4% today, +33.0% week) — $6.76 → $7.80 (+15.4% upside) Valuation: Sub-$10 consumer staples with a dividend and a real earnings inflection — the guidance raise from $0.57 midpoint to $0.75 midpoint (32% raise) is one of the largest percentage guidance hikes on today’s board. Upside: First YoY revenue growth quarter after a prolonged downturn, a massive guidance beat, and a tariff refund tailwind heading into back-to-school season when its core products (Sharpie, Elmer’s) are in peak demand. Risk: Volume is running at only 0.45x average — the move is real but not explosively volume-confirmed, and the stock has no 200-day SMA to anchor to (suggesting limited history at these levels). A 31% single-day move makes chasing uncomfortable. Stop reference: $5.97 (fib 23.6%)

Avoid

FCEL — Pure sector sympathy with no company-specific catalyst, remains unprofitable, and the stock pulled back hard from $36 just weeks ago; chasing a 30% move on Bloom Energy’s coattails with FCEL’s own fundamentals still broken is a momentum trap.

TRAX — Up 14% on the week and 27% in the past month with no fresh news visible today, trading near its all-time high at $47.78, and volume is a microscopic 0.01x average — a move this large on this little volume in a thinly traded name is a liquidity warning, not a signal.

RJET — Republic Airways beat Q2 and raised guidance, but the stock is already trading between the 23.6% and 38.2% fib retracement levels ($22.78 and $21.55) on below-average volume, and severe weather disruptions flagged for Q3 early in the quarter signal the next guide may come down — don’t buy the raise when Q3 headwinds are already disclosed.

WSB Sentiment Check

MU — WSB says: BEARISH (30% bullish) Claude says: AGREE — MU is trading below its 50-day SMA ($966) and well off its 6-month high of $1,213, and while memory demand is structurally strong, the stock has broken the $1,000 support level and the fib 38.2% at $872 is the next test; WSB’s bearish lean reflects real technical deterioration, not just capitulation panic.

MSFT — WSB says: BEARISH (30% bullish) Claude says: DISAGREE — WSB is flat-out wrong here; MSFT just posted its best day since 2008 on a genuine fundamental re-acceleration in Azure, is breaking out above its 50-day SMA of $399 toward the 6-month high, and the bearish 30% bullish reading is likely legacy positioning from before last night’s print — the technical breakout is real and institutional.

AAPL — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY — AAPL is below its 50-day SMA ($309.38) and has pulled back from its $340 high to $302, sitting right at the 38.2% fib support ($304.30); WSB’s bullishness has a reasonable technical basis as a bounce candidate from support, but if results disappointed (headline news suggests weakness today), the support test is real and a break below $293 (fib 50%) would be ugly — wait for the support to hold before buying the dip.

RDDT — WSB says: BULLISH (80% bullish) Claude says: DISAGREE — Reddit beat earnings but dropped 15% on search traffic dependency warnings, is now below its 50-day SMA ($175.43), and is testing the 61.8% fib retracement at $152.95 — the chart is broken post-earnings, not coiling for a bounce; “buy the dip on a structural vulnerability disclosure” is exactly the kind of trade WSB loses on.

AMZN — WSB says: BULLISH (80% bullish) Claude says: AGREE — Amazon’s Q2 beat with AWS AI/chip business at a $25B run rate is a genuine catalyst, the stock is near its 6-month high of $274.99 at $268.22, and the fib extension at $295.72 is a realistic near-term target; WSB’s bullishness is fundamentally and technically grounded for once.

Earnings Scorecard

RDDT — BEAT | Stock: -15.0% | Reported: Yesterday After Close The earnings beat was real but the “choppy” search traffic warning is a structural red flag — Google algorithm dependency is an existential risk for Reddit’s monetization model, and the market was right to sell the news; this is not a buy-the-dip until search traffic stabilizes. Sell-the-rip on any bounce toward $165-170.

MA — BEAT | Stock: -2.26% | Reported: Yesterday Mastercard’s beat was solid and the -2.3% reaction looks like profit-taking after a strong run rather than a genuine negative read — the business “is much more than a card company” headline suggests expanding revenue streams; this mild dip is buyable for patient holders. Reaction was overdone to the downside.

HOOD — BEAT | Stock: +2.19% | Reported: Yesterday Record revenue and Gold subscribers but still 44% below its all-time high, with Goldman and Barclays cutting targets despite the beat — the muted +2.2% reaction says the market sees Robinhood as a cyclical trading-volume beneficiary, not a compounding franchise; hold but don’t chase into a potential volume-cycle fade.

ABBV — BEAT on Revenue | Stock: -1.68% | Reported: Yesterday Revenue beat but the profit forecast cut tied to the Apogee deal acquisition cost is the culprit for the mild selloff — this is a hold, not a trade; the -1.7% reaction is proportionate to the EPS guide reduction, and the pipeline is still intact.

EA — BEAT | Stock: +0.12% | Reported: Yesterday A flat reaction to an earnings beat says the market has no conviction in Electronic Arts’ growth story right now — when a beat moves a stock 12 basis points, the Street is telling you guidance disappointed or the core gaming business has structural concerns; avoid until there’s a visible catalyst beyond quarterly noise.